Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Tirbanibulin bulk supplier for pharma manufacturers

Tirbanibulin 1% Suppliers & Bulk Manufacturers

Available Forms: Ointment

Available Strengths: 1%

Reference Brands: Klisyri (USA)

Category: Derma Drugs

Tirbanibulin is a microtubule inhibitor that binds to tubulin and inhibits tubulin polymerization. It also inhibits Src‑kinase signalling pathways. By doing so, it arrests cell division in rapidly dividing skin cells affected by sun damage, leading to their death. It is used for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis on the face or scalp, helping clear precancerous skin lesions and reduce the risk of progression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Tirbanibulin — third party manufacturing & bulk supply

Tirbanibulin 1% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Tirbanibulin is supplied as Ointment — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tirbanibulin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Tirbanibulin →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Tirbanibulin is used to treat actinic keratosis, a precancerous skin condition caused by sun damage. It works by inhibiting tubulin polymerization and Src kinase signaling, which disrupts the growth of abnormal skin cells.

Tirbanibulin is made from the active pharmaceutical ingredient tirbanibulin, a synthetic molecule that targets cellular microtubules and signaling pathways involved in abnormal cell proliferation.

The trade name is Klisyri.

Klisyri is manufactured by Almirall, S.A.

The generic name is tirbanibulin.

The primary brand name is Klisyri.

It is manufactured in approved pharmaceutical facilities in Europe and other regions depending on regulatory approvals.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.